← Open Payments lookup

CHRISTOPHER GALBREATH: Open Payments

NPI 1235190521 · FAIRPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,963 in 141 payments from 11 companies in 2025. Trend: 2023 $2,665 · 2024 $2,247 · 2025 $2,963

Food & beverage: $2,963
CompanyPaymentsAmount
ABBVIE INC.37$615
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$614
Vanda Pharmaceuticals Inc.19$395
Otsuka America Pharmaceutical, Inc.11$284
Axsome Therapeutics, Inc.10$233
Teva Pharmaceuticals USA, Inc.11$224
Takeda Pharmaceuticals U.S.A., Inc.8$190
Supernus Pharmaceuticals, Inc.5$137
E.R. Squibb & Sons, L.L.C.4$93
Alkermes, Inc.4$89

Products named: VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, Auvelity, AUSTEDO XR, TRINTELLIX, Qelbree.

Industry payments across NY — which companies pay providers there.